Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Dermatology

Free Subscription 08.12.2025 2 BMC Cancer 2 Cancer Res 3 Int J Cancer 1 Intern Med 6 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Cancer

1. BAS O, Inci BK, Eroglu I, Efil SC, et al
   Real-world evidence of ribociclib-induced hepatotoxicity in patients with breast cancer: a multi-center experience.
   BMC Cancer. 2025;25:1831.
   PubMed         Abstract available
   
   
2. HAFEEZ A, Basit M, Zafar S, Shabbir M, et al
   Comprehensive analysis of gene expression alterations in breast cancer patients via PKCtheta-TBK1-mTORC1 signaling pathway.
   BMC Cancer. 2025;25:1844.
   PubMed         Abstract available
   
   

   
   Cancer Res

3. ARNOUK SM, Kancheva D, Van Damme H, Courtoy GE, et al
   Depleting IL1R2+ Tumor-Infiltrating Regulatory T Cells with an ADCC-Prone Nanobody Construct Boosts the Efficacy of Anti-PD-1 Immunotherapy.
   Cancer Res. 2025;85:4681-4700.
   PubMed         Abstract available
   
   
4. MOLDRUP RIJ, Terp MG, Jakobsen ST, Ravnsborg T, et al
   SWI/SNF Functions as a Gatekeeper of Enhancer Chromatin Access to Control Progression of Mesenchymal Triple-Negative Breast Cancer.
   Cancer Res. 2025 Sep 10. doi: 10.1158/0008-5472.CAN-24-1660.
   PubMed         Abstract available
   
   

   
   Int J Cancer

5. TANG B, Yu Y, Wan J, Yu C, et al
   Immune checkpoint inhibitor-induced vitiligo: A large-scale real world pharmacovigilance study.
   Int J Cancer. 2026;158:738-751.
   PubMed         Abstract available
   
   
6. VANDRAAS KF, Hjorth S, Trewin-Nybraten CB, Ursin G, et al
   Anti-Her2 therapy patterns in metastatic breast cancer-Real-world data suggest undertreatment.
   Int J Cancer. 2025 Sep 2. doi: 10.1002/ijc.70120.
   PubMed         Abstract available
   
   
7. JOHN EM, Koo J, Keegan TH, Gomez SL, et al
   Reproductive factors and risk of contralateral breast cancer by age and hormone receptor status: The California Breast Cancer Survivorship Consortium.
   Int J Cancer. 2025 Aug 16. doi: 10.1002/ijc.70089.
   PubMed         Abstract available
   
   

   
   Intern Med

8. NAGAO N, Funakubo Asanuma Y, Kitahara T, Matsuda H, et al
   A Retrospective Observational Study of Otitis Media with Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis.
   Intern Med. 2025;64:3334-3342.
   PubMed         Abstract available
   
   

   
   PLoS One

9. HOSSIN AY, Rahman MN, Hasan MM, Karim A, et al
   Evaluation of dihydropyranocoumarins as potent inhibitors against triple-negative breast cancer: An integrated of in silico, quantum & molecular modeling approaches.
   PLoS One. 2025;20:e0334939.
   PubMed         Abstract available
   
   
10. ALSALAH JH
    Incidental extramammary findings on breast magnetic resonance imaging: Prevalence and recommended diagnostic follow-up.
    PLoS One. 2025;20:e0319373.
    PubMed         Abstract available
    
    
11. BRAZ JM, Jewell M, Bhardwaj K, Rodriguez-Rosado S, et al
    Differential contribution of alpha2delta auxiliary subunits of voltage-gated calcium channels in mouse models of pain and itch.
    PLoS One. 2025;20:e0337701.
    PubMed         Abstract available
    
    
12. WEDAGE WMM, Harischandra IN, Weerasena OVDSJ, Senanayake SASC, et al
    Demographic history and population structure of Phlebotomus argentipes (Diptera: Psychodidae) complex, the leishmaniasis vector in Sri Lanka.
    PLoS One. 2025;20:e0337428.
    PubMed         Abstract available
    
    
13. ZHAO Y, Lan S, Li X, Deng Y, et al
    Investigating the mechanism of oridonin against triple-negative breast cancer based on network pharmacology and molecular docking.
    PLoS One. 2025;20:e0332697.
    PubMed         Abstract available
    
    
14. LIANG B, Duan Z, Long S, Zhou P, et al
    Infiltration of CXCL9+ macrophages confers a favorable prognosis in breast cancer: Insights from an integrated single-cell RNA and bulk RNA sequencing study.
    PLoS One. 2025;20:e0337175.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dermatology is free of charge.